Boardroom Alpha
Boardroom Alpha
CW · Additional Proxy Materials (DEFA14A) · Filed March 26, 2026

Curtiss Wright Corp — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
March 26, 2026
Ticker
CW
Accession
0000930413-26-000879
Boardroom Alpha · Filing insights

Board-backed slate up for vote; Curtiss-Wright recommends all director nominees, Deloitte audit, and say-on-pay advisory.

About Curtiss Wright Corp
Market cap
$26.6B
1Y TSR
+57.5%
3Y TSR
+61.9%
Board grade
A
Sector
Industrials
CEO
Lynn J Bamford
Last annual meeting: May 7, 2026 · View full Curtiss Wright Corp profile →

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

 

Filed by the Registrant x
 
Filed by a Party other than the Registrant o
 
Check the appropriate box:
 
o   Preliminary Proxy Statement
     
o   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
     
o   Definitive Proxy Statement
     
x   Definitive Additional Materials
     
o   Soliciting Material Pursuant to §240.14a-12

 

CURTISS-WRIGHT CORPORATION

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

         
Payment of Filing Fee (Check the appropriate box):
 
x   No fee required.
     
o   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
     
    (1)   Title of each class of securities to which transaction applies:
         
         
    (2)   Aggregate number of securities to which transaction applies:
         
         
    (3)   Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
         
         
    (4)   Proposed maximum aggregate value of transaction:
         
         
    (5)   Total fee paid:
         
         
 
o   Fee paid previously with preliminary materials.
     
o   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
     
    (1)   Amount Previously Paid:
         
         
    (2)   Form, Schedule or Registration Statement No.:
         
         
    (3)   Filing Party:
         
         
    (4)   Date Filed:
         
         
 

 

      Your Vote Counts!  
      CURTISS-WRIGHT CORPORATION  
      2026 Annual Meeting  
      Vote by May 6, 2026  
   



CURTISS-WRIGHT CORPORATION
C/O BROADRIDGE
P.O. BOX 1342
BRENTWOOD, NY 11717

  11:59 PM ET  
       
       
         
         
         
         
         
         
V84547-P45788      

 

You invested in CURTISS-WRIGHT CORPORATION and it’s time to vote!

You have the right to vote on proposals being presented at the Annual meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on May 7, 2026.

 

Get informed before you vote

View the Notice and Proxy Statement and Combined Business Review/2025 Annual Report on Form 10-K to security holders online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 23, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

 

     
For complete information and to vote, visit www.ProxyVote.com
Control #
     

 

Smartphone users

 

Point your camera here and
vote without entering a
control number

           

Vote in Person at the Meeting*

 

May 7, 2026
1:00 p.m., Local Time


 

 

Homewood Suites by Hilton
125 Harbour Place Drive
Davidson, North Carolina 28036

 

       

 

* Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.
 
Vote at www.ProxyVote.com  

 

THIS IS NOT A VOTABLE BALLOT

 

This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters.

 

 

Voting Items Board
Recommends
1. Election of Directors  
  Nominees:      
  01) Lynn M. Bamford 06) William F. Moran   For
  02) Bruce D. Hoechner 07) Robert J. Rivet  
  03) Jeffrey J. Lyash 08) Peter C. Wallace  
  04) Glenda J. Minor 09) Larry D. Wyche  
  05) Anthony J. Moraco      
2. To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for 2026  For
3. An advisory (non-binding) vote to approve the compensation of the Company’s named executive officers  For
NOTE: Such other business as may properly come before the meeting or any adjournment thereof.
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.

 

V84548-P45788

 
From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Curtiss Wright Corp (CW)

Reference

Frequently asked questions

When did Curtiss Wright Corp file this DEFA14A?
Curtiss Wright Corp (CW) filed this Additional Proxy Materials (DEFA14A) with the SEC on March 26, 2026. The accession number assigned by EDGAR is 0000930413-26-000879.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Board-backed slate up for vote; Curtiss-Wright recommends all director nominees, Deloitte audit, and say-on-pay advisory. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Curtiss Wright Corp's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Curtiss Wright Corp has filed under CIK 26324, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer